Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events

被引:26
作者
Pagnamenta, Alberto [1 ,2 ]
Rabito, Giovanni [3 ]
Arosio, Alessandra [3 ]
Perren, Andreas [1 ,2 ]
Malacrida, Roberto [1 ,2 ]
Barazzoni, Fabrizio [4 ]
Domenighetti, Guido [1 ,2 ]
机构
[1] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Bellinzona, Switzerland
[2] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Lugano, Switzerland
[3] Reg Hosp Locarno, Div Qual Improvement & Risk Management, Locarno, Switzerland
[4] EOC, Med Area Unit, Bellinzona, Switzerland
来源
ANNALS OF INTENSIVE CARE | 2012年 / 2卷
关键词
Adverse events; Medical errors; Patient safety; Quality improvement; Intensive care; Reliability; PATIENT SAFETY; QUALITY IMPROVEMENT; MEDICATION ERRORS; PHARMACISTS; FRAMEWORK; OUTCOMES;
D O I
10.1186/2110-5820-2-47
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Adverse events (AEs) frequently occur in intensive care units (ICUs) and affect negatively patient outcomes. Targeted improvement strategies for patient safety are difficult to evaluate because of the intrinsic limitations of reporting crude AE rates. Single interventions influence positively the quality of care, but a multifaceted approach has been tested only in selected cases. The present study was designed to evaluate the rate, types, and contributing factors of emerging AEs and test the hypothesis that a multifaceted intervention on medication might reduce drug-related AEs. Methods: This is a prospective, multicenter, before-and-after study of adult patients admitted to four ICUs during a 24-month period. Voluntary, anonymous, self-reporting of AEs was performed using a detailed, locally designed questionnaire. The temporal impact of a multifaceted implementation strategy to reduce drug-related AEs was evaluated using the risk-index scores methodology. Results: A total of 2,047 AEs were reported (32 events per 100 ICU patient admissions and 117.4 events per 1,000 ICU patient days) from 6,404 patients, totaling 17,434 patient days. Nurses submitted the majority of questionnaires (n = 1,781, 87%). AEs were eye-witnessed in 49% (n = 1,003) of cases and occurred preferentially during an elective procedure (n = 1,597, 78%) and on morning shifts (n = 1,003, 49%), with a peak rate occurring around 10 a. m. Drug-related AEs were the most prevalent (n = 984, 48%), mainly as a consequence of incorrect prescriptions. Poor communication among caregivers (n = 776) and noncompliance with internal guidelines (n = 525) were the most prevalent contributing factors for AE occurrence. The majority of AEs (n = 1155, 56.4%) was associated with minimal, temporary harm. Risk-index scores for drug-related AEs decreased from 10.01 +/- 2.7 to 8.72 +/- 3.52 (absolute risk difference 1.29; 95% confidence interval, 0.88-1.7; p < 0.01) following the introduction of the intervention. Conclusions: AEs occurred in the ICU with a typical diurnal frequency distribution. Medication-related AEs were the most prevalent. By applying the risk-index scores methodology, we were able to demonstrate that our multifaceted implementation strategy focused on medication-related adverse events allowed to decrease drug related incidents.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Incidence of drug-related adverse events related to the use of high-alert drugs: A systematic review of randomized controlled trials
    Menezes, Michelle Santos
    Doria, Grace Anne Azevedo
    Valenca-Feitosa, Fernanda
    Pereira, Sylmara Nayara
    Silvestre, Carina Carvalho
    de Oliveira, Alfredo Dias
    Lobo, Iza Maria Fraga
    Quintans-Junior, Lucindo Jose
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2024, 14
  • [42] Using technology to prevent adverse drug events in the intensive care unit
    Hassan, Erkan
    Badawi, Omar
    Weber, Robert J.
    Cohen, Henry
    CRITICAL CARE MEDICINE, 2010, 38 : S97 - S105
  • [43] Association between nursing work conditions and adverse events in neonatal and pealatric Intensive Care Units
    Sanches Maziero, Eliane Cristina
    de Almeida Cruz, Elaine Drehmer
    Alpendre, Francine Taporosky
    Brandao, Marilise Borges
    Rodrigues Teixeira, Fabiana Ferreira
    Krainski, Elias Teixeira
    REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2020, 54 : 1 - 8
  • [44] An Intervention to Optimize Attitudes Toward Adverse Events Reporting Among Tunisian Critical Care Nurses
    Tlili, Mohamed Ayoub
    Aouicha, Wiem
    Sahli, Jihene
    Mtiraoui, Ali
    Ajmi, Thouraya
    Laatiri, Houyem
    Chelbi, Souad
    Ben Rejeb, Mohamed
    Mallouli, Manel
    JOURNAL OF PATIENT SAFETY, 2022, 18 (05) : E872 - E876
  • [45] Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS)
    Li, Xianlin
    Shang, Nan
    Yan, Qianci
    Yue, Xiunan
    Liu, Yang
    Zheng, Xiaojun
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 183 - 192
  • [46] An intervention to decrease narcotic-related adverse drug events in children's hospitals
    Sharek, Paul J.
    McClead, Richard E., Jr.
    Taketomo, Carol
    Luria, Joseph W.
    Takata, Glenn S.
    Walti, Beverly
    Tanski, Marla
    Nelson, Carla
    Logsdon, Tina R.
    Thurm, Cary
    Federico, Frank
    PEDIATRICS, 2008, 122 (04) : E861 - E866
  • [47] Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
    Xiaoying Gu
    Su Zhang
    Xuejiao Yang
    Tao Guan
    Zhenyu Hou
    Manqing Cao
    Huikai Li
    Ti Zhang
    BMC Gastroenterology, 22
  • [48] Adverse events and comparison of systematic and voluntary reporting from a paediatric intensive care unit
    Silas, Reshma
    Tibballs, James
    QUALITY & SAFETY IN HEALTH CARE, 2010, 19 (06): : 568 - 571
  • [49] Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
    Wang, Lingling
    Mao, Zhenyu
    Zheng, Pengdou
    Zi, Guisha
    Zhang, Fengqin
    Zhu, Xiaoyan
    Chen, Lixiang
    Liu, Huiguo
    Zhou, Ling
    Wei, Shuang
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [50] Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
    Gu, Xiaoying
    Zhang, Su
    Yang, Xuejiao
    Guan, Tao
    Hou, Zhenyu
    Cao, Manqing
    Li, Huikai
    Zhang, Ti
    BMC GASTROENTEROLOGY, 2022, 22 (01)